New perspectives of HPMA-based copolymers derived by post-polymerization modification.

Area of Science:

• Polymer Chemistry
• Biomedical Engineering
• Materials Science

Background:

• Poly[N-(2-hydroxypropyl) methacrylamide] (HPMA) polymers were among the first polymer drug conjugates used clinically.
• Significant efforts have focused on enhancing HPMA-based copolymers for diverse biomedical uses.

Purpose of the Study:

• To highlight multifunctional HPMA-based copolymers synthesized via controlled radical polymerization and post-polymerization modification.
• To showcase the versatility of these copolymers as targeted drug carriers and in advanced biomedical applications.

Main Methods:

• Controlled radical polymerization to precisely tailor polymer microstructure (molecular weight, dispersity, block formation, end-group functionalization).
• Post-polymerization modification of activated ester precursor polymers using aminolysis to introduce diverse functional groups.

Main Results:

• Achieved precise control over polymer microstructure and facile introduction of various functional groups.
• Developed versatile, targeted drug carriers suitable for sophisticated molecular imaging.
• Demonstrated potential for advanced carriers in tumor immunotherapy.

Conclusions:

• The described approach enables the creation of multifunctional HPMA copolymers with tailored properties.
• These advanced HPMA copolymers are valuable for molecular imaging and show significant potential in tumor immunotherapy.
• HPMA-based copolymers represent a versatile platform for sophisticated drug delivery systems.